A safe and effective vaccine against COVID-19 is generally regarded as the only way out of the COVID-19 crisis, especially if a widely predicted second wave develops. In this episode, RSM President-Elect Roger Kirby is joined by Professor Robin Shattock, Head of Mucosal Infection and Immunity at Imperial College London and Dr Thomas Breuer, Chief Medical Officer at GSK Vaccines to discuss how groups around the world are urgently working to develop a vaccine, and how it will be developed, tested, manufactured and become available at large scale.
Recorded on Tuesday 9 June 2020 as part of the Royal Society of Medicine’s COVID-19 Series.
Latest posts by Hippocratic Post (see all)
- Diabetes drug may have hidden health benefits for older adults - 4th February 2025
- Metastatic cancers: Protein that fuels treatment resistant tumours may be key to better outcomes - 4th February 2025
- UK oesophageal cancer rate is higher than most of Europe - 31st January 2025